Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05404100Completed

Effects of Aortic Valve Replacement on Myocardial T1 Values in Severe Aortic Valve Stenosis

Role: collaborator

NCT05597657Not ApplicableCompleted

Normal Variation of T1 Values With Cardiac Magnetic Resonance in Healthy Individuals

Role: collaborator

NCT01817998Not ApplicableCompleted

Atrial Fibrillation (AF) and Physical Exercise

Role: collaborator

NCT00639054Completed

The Molecular Characterization of Multiple Myeloma at Relapse

Role: collaborator

All 4 trials loaded